These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3533393)

  • 1. Hyperlipidaemia of diabetes.
    Gibbons GF
    Clin Sci (Lond); 1986 Nov; 71(5):477-86. PubMed ID: 3533393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid disorders in diabetes.
    Goldberg RB
    Diabetes Care; 1981; 4(5):561-72. PubMed ID: 6751732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic dyslipidemia.
    Kreisberg RA
    Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperlipidemia during diabetes mellitus. Recent developments].
    Guerci B; Ziegler O; Drouin P
    Presse Med; 1994 Jan; 23(2):82-8. PubMed ID: 8140078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of intestinal lipoprotein metabolism in diabetes mellitus and metabolic syndrome.
    Arca M
    Atheroscler Suppl; 2015 Feb; 17():12-6. PubMed ID: 25659871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic dyslipidaemia: from basic research to clinical practice.
    Taskinen MR
    Diabetologia; 2003 Jun; 46(6):733-49. PubMed ID: 12774165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease.
    Quaschning T; Krane V; Metzger T; Wanner C
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S14-9. PubMed ID: 11576915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postprandial lipoproteins in non-insulin-dependent diabetes mellitus.
    Coppack SW
    Diabet Med; 1997 Aug; 14 Suppl 3():S67-74. PubMed ID: 9272617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of decreased serum adiponectin for type IIb hyperlipidaemia and increased cholesterol levels of very-low-density lipoprotein in type II diabetic patients.
    Yoshida H; Hirowatari Y; Kurosawa H; Tada N
    Clin Sci (Lond); 2005 Sep; 109(3):297-302. PubMed ID: 15907189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein metabolism in diabetes.
    Howard BV
    Curr Opin Lipidol; 1994 Jun; 5(3):216-20. PubMed ID: 7952916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic fate of plasma lipoproteins in normal subjects and in patients with insulin resistance and endogenous hypertriglyceridaemia.
    Kissebah AH; Alfarsi S; Adams PW; Wynn V
    Diabetologia; 1976 Oct; 12(5):501-9. PubMed ID: 185113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic dyslipidaemia: current treatment recommendations.
    Best JD; O'Neal DN
    Drugs; 2000 May; 59(5):1101-11. PubMed ID: 10852642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assembly and secretion of hepatic very-low-density lipoprotein.
    Gibbons GF
    Biochem J; 1990 May; 268(1):1-13. PubMed ID: 2188646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes of lipoproteins during insulin therapy in diabetes mellitus type 1].
    Pantelinac P
    Med Pregl; 2009; 62 Suppl 3():66-9. PubMed ID: 19702119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyslipidaemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis.
    Vergès BL
    Diabetes Metab; 1999 Jun; 25 Suppl 3():32-40. PubMed ID: 10421991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis.
    Ginsberg HN
    Diabetes Care; 1991 Sep; 14(9):839-55. PubMed ID: 1959476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus.
    Kissebah AH; Alfarsi S; Evans DJ; Adams PW
    Diabetes; 1982 Mar; 31(3):217-25. PubMed ID: 7152129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.